LINCOMYCIN injection

Nazione: Stati Uniti

Lingua: inglese

Fonte: NLM (National Library of Medicine)

Principio attivo:

LINCOMYCIN HYDROCHLORIDE (UNII: M6T05Z2B68) (LINCOMYCIN - UNII:BOD072YW0F)

Commercializzato da:

Aspen Veterinary Resources

Via di somministrazione:

INTRAMUSCULAR

Tipo di ricetta:

PRESCRIPTION

Indicazioni terapeutiche:

INDICATIONS FOR SWINE: Lincomycin 300 is indicated for the treatment of infectious forms of arthritis caused by organisms sensitive to its activity. This includes most of the organisms responsible for the various infectious arthritides in swine, such as staphylococci, streptococci, Erysipelothrix and Mycoplasma spp. It is also indicated for the treatment of mycoplasma pneumonia. CONTRAINDICATIONS: As with all drugs, the use of Lincomycin 300 is contraindicated in animals previously found to be hypersensitive to the drug. Human Warnings: Not for human use. Keep out of reach of children.

Dettagli prodotto:

HOW SUPPLIED: Lincomycin 300, 300 mg/mL: For use in swine weighing 300 pounds or more. Supplied in 100 mL multiple dose vial.

Stato dell'autorizzazione:

Abbreviated New Animal Drug Application

Scheda tecnica

LINCOMYCIN- LINCOMYCIN INJECTION
ASPEN VETERINARY RESOURCES
----------
LINCOMYCIN 300
(LINCOMYCIN INJECTION)
FOR USE IN SWINE WEIGHING 300 POUNDS OR MORE.
FOR INTRAMUSCULAR USE IN SWINE ONLY
CAUTION: Federal law restricts this drug to use by or on the order of
a licensed
veterinarian.
Lincomycin 300 contains lincomycin hydrochloride, an antibiotic
produced by
_Streptomyces lincolnensis var. lincolnensis_ which is chemically
distinct from all other
clinically available antibiotics and is isolated as a white
crystalline solid.
INDICATIONS FOR SWINE:
Lincomycin 300 is indicated for the treatment of infectious forms of
arthritis caused by
organisms sensitive to its activity. This includes most of the
organisms responsible for
the various infectious arthritides in swine, such as staphylococci,
streptococci,
_Erysipelothrix_ and _Mycoplasma _spp.
It is also indicated for the treatment of mycoplasma pneumonia.
CONTRAINDICATIONS:
As with all drugs, the use of Lincomycin 300 is contraindicated in
animals previously
found to be hypersensitive to the drug.
RESIDUE WARNING: Swine intended for human consumption should not be
slaughtered
within 48 hours of latest treatment.
HUMAN WARNINGS: Not for human use. Keep out of reach of children.
CAUTION:
If no improvement is noted within 48 hours, consult a veterinarian.
ADVERSE REACTIONS:
The intramuscular administration to swine may cause a transient
diarrhea or loose
stools. Although this effect has rarely been reported, one must be
alert to the possibility
that it may occur. Should this occur, it is important that the
necessary steps be taken to
prevent the effects of dehydration.
The Safety Data Sheet (SDS) contains more detailed occupational safety
information. To
report adverse drug events, for technical assistance or to obtain a
copy of the SDS,
contact Aspen Veterinary Resources at
[e-mail]. For
additional information about adverse drug experience reporting for
animal drugs,
contact FDA at 1-888-FDA-VETS or online at www.fda.gov/reportanimalae.
DOSAG